The ST2/IL-33 Pathway in Adult and Paediatric Heart Disease and Transplantation
ST2 is a member of interleukin 1 receptor family with soluble sST2 and transmembrane ST2L isoforms. The ligand of ST2 is IL-33, which determines the activation of numerous intracytoplasmic mediators following the binding with ST2L and IL-1RAcP, leading to nuclear signal and cardiovascular effect. Di...
Main Authors: | Giacomina Brunetti, Barbara Barile, Grazia Paola Nicchia, Francesco Onorati, Giovanni Battista Luciani, Antonella Galeone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/6/1676 |
Similar Items
-
Predicting Immuno-Metabolic Complications After Allogeneic Hematopoietic Cell Transplant with the Cytokine Interleukin-33 (IL-33) and its Receptor Serum-Stimulation 2 (ST2)
by: Uttam K. Rao, et al.
Published: (2020-05-01) -
IL-33 and the PKA Pathway Regulate ILC2 Populations Expressing IL-9 and ST2
by: Enrique Olguín-Martínez, et al.
Published: (2022-05-01) -
The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications
by: Nathan Ryan, et al.
Published: (2020-04-01) -
IL-33/ST2 axis of human amnion fibroblasts participates in inflammatory reactions at parturition
by: Wen-jia Lei, et al.
Published: (2023-07-01) -
Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response
by: Takahiro Kawauchi, et al.
Published: (2017-07-01)